File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets

TitleIPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets
Authors
Garland, Suzanne M.Bhatla, NeerjaWoo, Yin LingStanley, MargaretKaufmann, AndreasBrotherton, JuliaMoscicki, Anna BarbaraGiuliano, AnnaChan, KarenFeldman, SarahWentzensen, NicolasChatzistamatiou, Kimon
KeywordsHuman papillomavirus (HPV)
Vaccine supply constraint
Issue Date2-Dec-2024
PublisherElsevier
Citation
Vaccine, 2024, v. 42, n. 26 How to Cite?
DOI: http://dx.doi.org/10.1016/j.vaccine.2024.126400
AbstractThe global supply of human papillomavirus (HPV) prophylactic vaccines has been constrained since 2020.Vaccine manufacturers have increased capacity and new HPV vaccines are now available. Vaccine supply is now able to meet the full HPV vaccine demand which has been achieved earlier than predicted.
Persistent Identifierhttp://hdl.handle.net/10722/353892
ISSN
0264-410X
2023 Impact Factor: 4.5
2023 SCImago Journal Rankings: 1.342

 

DC FieldValueLanguage
dc.contributor.authorGarland, Suzanne M.-
dc.contributor.authorBhatla, Neerja-
dc.contributor.authorWoo, Yin Ling-
dc.contributor.authorStanley, Margaret-
dc.contributor.authorKaufmann, Andreas-
dc.contributor.authorBrotherton, Julia-
dc.contributor.authorMoscicki, Anna Barbara-
dc.contributor.authorGiuliano, Anna-
dc.contributor.authorChan, Karen-
dc.contributor.authorFeldman, Sarah-
dc.contributor.authorWentzensen, Nicolas-
dc.contributor.authorChatzistamatiou, Kimon-
dc.date.accessioned2025-01-28T00:35:41Z-
dc.date.available2025-01-28T00:35:41Z-
dc.date.issued2024-12-02-
dc.identifier.citationVaccine, 2024, v. 42, n. 26-
dc.identifier.issn0264-410X-
dc.identifier.urihttp://hdl.handle.net/10722/353892-
dc.description.abstractThe global supply of human papillomavirus (HPV) prophylactic vaccines has been constrained since 2020.Vaccine manufacturers have increased capacity and new HPV vaccines are now available. Vaccine supply is now able to meet the full HPV vaccine demand which has been achieved earlier than predicted.-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofVaccine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectHuman papillomavirus (HPV)-
dc.subjectVaccine supply constraint-
dc.titleIPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets-
dc.typeArticle-
dc.identifier.doi10.1016/j.vaccine.2024.126400-
dc.identifier.scopuseid_2-s2.0-85205376195-
dc.identifier.volume42-
dc.identifier.issue26-
dc.identifier.eissn1873-2518-
dc.identifier.issnl0264-410X-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats